US FDA approves Bristol Myers’ colorectal cancer therapy By Reuters
By Christy Santhosh and Unnamalai L (Reuters) -The U.S. Food and Drug Administration has approved Bristol Myers (NYSE:) Squibb's combination ...
By Christy Santhosh and Unnamalai L (Reuters) -The U.S. Food and Drug Administration has approved Bristol Myers (NYSE:) Squibb's combination ...
Leanne Sherred, a pediatric speech therapist, has long encountered challenges putting caregiver-led therapy into practice in traditional care settings. Research ...
Mario Tama The U.S. Food and Drug Administration (FDA) on Thursday approved Amgen’s (NASDAQ:AMGN) targeted cancer therapy, Imdelltra, as a ...
Capricor Therapeutics (NASDAQ:) has completed a significant phase in the development of its cardiac cell therapy, CAP-1002, for Duchenne muscular ...
Bet_Noire Pfizer (NYSE:PFE) said it has received FDA approval for its one-time gene therapy Beqvez for the treatment of certain ...
CULVER CITY, Calif. - ImmunityBio, Inc. (NASDAQ: IBRX) announced today that ANKTIVA, in combination with Bacillus Calmette-Guérin (BCG), has received ...
By Leroy Leo and Michael Erman (Reuters) -The U.S. Food and Drug Administration on Tuesday approved Merck's treatment for adults ...
© Reuters. On Monday, Edwards Lifesciences (NYSE:), a prominent player in the medical technology industry, saw its share price target ...
Israeli phage therapy company BiomX (NYSE: PHGE) has announced a merger with Adaptive Phage Therapeutics (APT). The merged company ...
© Reuters. NEW HOPE, Pa. - Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO), a biomedical company, has announced new data on the ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.